Drug
Afabicin clinical trials
Also written Debio 1450.
Keep track of what changes. Save the afabicin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
7 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses afabicin is read from its arms, and is right about nine times in ten.
Testing it · 7
- Renal Impairment Pharmacokinetics (PK) Trial of AfabicinNot yet recruitingPhase 1Debiopharm International SANCT07758608Written as Afabicin Oral
- Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to StaphylococcusTerminatedPhase 2Debiopharm International SANCT03723551Written as Afabicin
- Study of Debio 1450 for Bacterial Skin InfectionsCompletedPhase 2Debiopharm International SANCT02426918Written as Debio 1450 IV
- A Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy SubjectsCompletedPhase 1Debiopharm International SANCT03209648Written as Debio 1450
- Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement SurgeryCompletedPhase 1Debiopharm International SANCT02726438Written as Debio 1450
- A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy VolunteersCompletedPhase 1Debiopharm International SANCT02214433Written as Debio 1450 IV Solution
- A Single Dose Study of Debio 1450 in Healthy SubjectsCompletedPhase 1Debiopharm International SANCT02162199Written as Debio 1450
Codes
What other systems call afabicin · ClinicalTrials.gg INT001261
- MeSH (NLM) C000657127afabicinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) DMM8663H2RAFABICINConfirmed FDA, NLM, Wikidata
- Wikidata Q27276486afabicinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169766AfabicinOne source FDA
- DrugBank DB15268One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000657127 | afabicin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | DMM8663H2R | AFABICIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27276486 | afabicin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169766 | Afabicin | One source FDA |
| DrugBank | DB15268 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.